Published in Arch Gen Psychiatry on November 01, 2005
Targeting abnormal neural circuits in mood and anxiety disorders: from the laboratory to the clinic. Nat Neurosci (2007) 4.46
Reduced caudate and nucleus accumbens response to rewards in unmedicated individuals with major depressive disorder. Am J Psychiatry (2009) 3.96
DeltaFosB in brain reward circuits mediates resilience to stress and antidepressant responses. Nat Neurosci (2010) 3.47
Reconsidering anhedonia in depression: lessons from translational neuroscience. Neurosci Biobehav Rev (2010) 3.46
Neural responses to monetary incentives in major depression. Biol Psychiatry (2007) 2.62
Serotonergic function, two-mode models of self-regulation, and vulnerability to depression: what depression has in common with impulsive aggression. Psychol Bull (2008) 2.24
Imipramine treatment and resiliency exhibit similar chromatin regulation in the mouse nucleus accumbens in depression models. J Neurosci (2009) 2.18
Reduced capacity to sustain positive emotion in major depression reflects diminished maintenance of fronto-striatal brain activation. Proc Natl Acad Sci U S A (2009) 2.15
Targeted electrode-based modulation of neural circuits for depression. J Clin Invest (2009) 2.03
Depression, stress, and anhedonia: toward a synthesis and integrated model. Annu Rev Clin Psychol (2014) 1.85
The role of the nucleus accumbens and rostral anterior cingulate cortex in anhedonia: integration of resting EEG, fMRI, and volumetric techniques. Neuroimage (2009) 1.81
Reward circuitry dysfunction in psychiatric and neurodevelopmental disorders and genetic syndromes: animal models and clinical findings. J Neurodev Disord (2012) 1.73
Research Review: altered reward function in adolescent depression: what, when and how? J Child Psychol Psychiatry (2011) 1.51
Norman Cousins Lecture. Mechanisms of cytokine-induced behavioral changes: psychoneuroimmunology at the translational interface. Brain Behav Immun (2008) 1.42
Reward-related brain function as a predictor of treatment response in adolescents with major depressive disorder. Cogn Affect Behav Neurosci (2010) 1.32
IFN-alpha-induced motor slowing is associated with increased depression and fatigue in patients with chronic hepatitis C. Brain Behav Immun (2008) 1.30
Microstructural abnormalities in subcortical reward circuitry of subjects with major depressive disorder. PLoS One (2010) 1.29
Sex differences in the neural mechanisms mediating addiction: a new synthesis and hypothesis. Biol Sex Differ (2012) 1.27
Anxiety, depression, and cigarette smoking: a transdiagnostic vulnerability framework to understanding emotion-smoking comorbidity. Psychol Bull (2014) 1.25
Nicotine effects on affective response in depression-prone smokers. Psychopharmacology (Berl) (2007) 1.25
Functional brain imaging studies of youth depression: a systematic review. Neuroimage Clin (2013) 1.23
Anterior cingulate cortex γ-aminobutyric acid in depressed adolescents: relationship to anhedonia. Arch Gen Psychiatry (2011) 1.23
Long-lasting behavioral effects and recognition memory deficit induced by chronic mild stress in mice: effect of antidepressant treatment. Psychopharmacology (Berl) (2008) 1.21
Anhedonia and amotivation in psychiatric outpatients with fully remitted stimulant use disorder. Am J Addict (2008) 1.20
Neurobiological mechanisms of anhedonia. Dialogues Clin Neurosci (2008) 1.17
Prevalence of incompletely penetrant Huntington's disease alleles among individuals with major depressive disorder. Am J Psychiatry (2010) 1.16
Prefrontal dopaminergic and enkephalinergic synaptic accommodation in HIV-associated neurocognitive disorders and encephalitis. J Neuroimmune Pharmacol (2012) 1.08
Depression is related to an absence of optimistically biased belief updating about future life events. Psychol Med (2013) 1.08
A framework for the specificity of addictions. Int J Environ Res Public Health (2011) 1.07
Evaluation of reward processes in an animal model of depression. Psychopharmacology (Berl) (2006) 1.07
Deep brain stimulation of the human reward system for major depression--rationale, outcomes and outlook. Neuropsychopharmacology (2014) 1.06
Structural differences in adult orbital and ventromedial prefrontal cortex predicted by infant temperament at 4 months of age. Arch Gen Psychiatry (2010) 1.05
Identifying predictors, moderators, and mediators of antidepressant response in major depressive disorder: neuroimaging approaches. Am J Psychiatry (2015) 1.04
Neural correlates of idiographic goal priming in depression: goal-specific dysfunctions in the orbitofrontal cortex. Soc Cogn Affect Neurosci (2009) 1.03
Lateralized caudate metabolic abnormalities in adolescent major depressive disorder: a proton MR spectroscopy study. Am J Psychiatry (2007) 1.01
Anhedonia and the relative reward value of drug and nondrug reinforcers in cigarette smokers. J Abnorm Psychol (2014) 1.00
The possible role of the kynurenine pathway in anhedonia in adolescents. J Neural Transm (Vienna) (2011) 0.99
Anhedonia associated with stimulant use and dependence in a population-based sample of American adults. Exp Clin Psychopharmacol (2010) 0.98
The kynurenine pathway in adolescent depression: preliminary findings from a proton MR spectroscopy study. Prog Neuropsychopharmacol Biol Psychiatry (2009) 0.98
Where is the pleasure in that? Low hedonic capacity predicts smoking onset and escalation. Nicotine Tob Res (2012) 0.96
A new strategy for antidepressant prescription. Front Neurosci (2010) 0.96
Translational studies of goal-directed action as a framework for classifying deficits across psychiatric disorders. Front Syst Neurosci (2014) 0.96
Epigenetics and psychoneuroimmunology: mechanisms and models. Brain Behav Immun (2010) 0.95
Behavioral and neurobiological effects of deep brain stimulation in a mouse model of high anxiety- and depression-like behavior. Neuropsychopharmacology (2013) 0.95
Emotional dysfunction in Parkinson's disease. Behav Neurol (2011) 0.95
Brainstem aminergic nuclei and late-life depressive symptoms. JAMA Psychiatry (2013) 0.95
A final common pathway for depression? Progress toward a general conceptual framework. Neurosci Biobehav Rev (2007) 0.93
Selective alterations of the CB1 receptors and the fatty acid amide hydrolase in the ventral striatum of alcoholics and suicides. J Psychiatr Res (2009) 0.92
A meta-analysis of changes in brain activity in clinical depression. Front Hum Neurosci (2015) 0.87
MDMA alters emotional processing and facilitates positive social interaction. Psychopharmacology (Berl) (2014) 0.86
Mechanisms explaining transitions between tonic and phasic firing in neuronal populations as predicted by a low dimensional firing rate model. PLoS One (2010) 0.85
Anhedonia predicts altered processing of happy faces in abstinent cigarette smokers. Psychopharmacology (Berl) (2012) 0.84
Dopamine receptor gene expression in human amygdaloid nuclei: elevated D4 receptor mRNA in major depression. Brain Res (2008) 0.83
Sleep and dreaming are for important matters. Front Psychol (2013) 0.83
Visualization of the cocaine-sensitive dopamine transporter with ligand-conjugated quantum dots. ACS Chem Neurosci (2011) 0.82
Inflammation Effects on Motivation and Motor Activity: Role of Dopamine. Neuropsychopharmacology (2016) 0.81
The nucleus accumbens: a target for deep brain stimulation in resistant major depressive disorder. J Mol Psychiatry (2013) 0.81
Emotional traits predict individual differences in amphetamine-induced positive mood in healthy volunteers. Psychopharmacology (Berl) (2015) 0.80
Role of the Brain's Reward Circuitry in Depression: Transcriptional Mechanisms. Int Rev Neurobiol (2015) 0.80
The effects of chronic versus acute desipramine on nicotine withdrawal and nicotine self-administration in the rat. Psychopharmacology (Berl) (2008) 0.79
Adjunctive aripiprazole therapy with escitalopram in patients with co-morbid major depressive disorder and alcohol dependence: clinical and neuroimaging evidence. J Psychopharmacol (2013) 0.79
Neural substrates for the motivational regulation of motor recovery after spinal-cord injury. PLoS One (2011) 0.79
Affect and the brain's functional organization: a resting-state connectivity approach. PLoS One (2013) 0.79
Identification of a circuit-based endophenotype for familial depression. Psychiatry Res (2012) 0.79
Mapping anhedonia-specific dysfunction in a transdiagnostic approach: an ALE meta-analysis. Brain Imaging Behav (2016) 0.78
Lipopolysaccharide-induced depressive-like behavior is associated with α₁-adrenoceptor dependent downregulation of the membrane GluR1 subunit in the mouse medial prefrontal cortex and ventral tegmental area. Int J Neuropsychopharmacol (2014) 0.78
Influence of repetitive transcranial magnetic stimulation on psychomotor symptoms in major depression. Eur Arch Psychiatry Clin Neurosci (2009) 0.78
SIRT1 Mediates Depression-Like Behaviors in the Nucleus Accumbens. J Neurosci (2016) 0.78
Decision-Making Dysfunctions of Counterfactuals in Depression: Who Might I have Been? Front Psychiatry (2013) 0.78
Effect of OPRM1 and stressful life events on symptoms of major depression in African American adolescents. J Affect Disord (2014) 0.77
Delay discounting without decision-making: medial prefrontal cortex and amygdala activations reflect immediacy processing and correlate with impulsivity and anxious-depressive traits. Front Behav Neurosci (2015) 0.77
Subclinical depression severity is associated with distinct patterns of functional connectivity for subregions of anterior cingulate cortex. J Psychiatr Res (2015) 0.76
Enhanced subgenual cingulate response to altruistic decisions in remitted major depressive disorder. Neuroimage Clin (2014) 0.76
Ventromedial Prefrontal Cortex Damage Is Associated with Decreased Ventral Striatum Volume and Response to Reward. J Neurosci (2016) 0.76
Influence of depressive symptoms on dopaminergic treatment of Parkinson's disease. Front Neurol (2014) 0.76
[Bipolar disorder in childhood and adolescence]. Rev Bras Psiquiatr (2004) 0.75
A Possible Role of Anhedonia as Common Substrate for Depression and Anxiety. Depress Res Treat (2016) 0.75
Network-Guided Transcranial Magnetic Stimulation for Depression. Curr Behav Neurosci Rep (2017) 0.75
Effects of antipsychotic treatment on psychopathology and motor symptoms. A placebo-controlled study in healthy volunteers. Psychopharmacology (Berl) (2011) 0.75
Traumatic brain injury, boredom and depression. Behav Sci (Basel) (2013) 0.75
Mediating Role of the Reward Network in the Relationship between the Dopamine Multilocus Genetic Profile and Depression. Front Mol Neurosci (2017) 0.75
Toward discovery science of human brain function. Proc Natl Acad Sci U S A (2010) 15.22
A meta-analysis of cytokines in major depression. Biol Psychiatry (2009) 7.16
Sedative hypnotics in older people with insomnia: meta-analysis of risks and benefits. BMJ (2005) 6.57
T1, T2 relaxation and magnetization transfer in tissue at 3T. Magn Reson Med (2005) 6.17
Allele-specific FKBP5 DNA demethylation mediates gene-childhood trauma interactions. Nat Neurosci (2012) 4.71
Targeting abnormal neural circuits in mood and anxiety disorders: from the laboratory to the clinic. Nat Neurosci (2007) 4.46
Toward a neuroimaging treatment selection biomarker for major depressive disorder. JAMA Psychiatry (2013) 4.12
A whole brain fMRI atlas generated via spatially constrained spectral clustering. Hum Brain Mapp (2011) 3.75
Antipsychotic drug use and mortality in older adults with dementia. Ann Intern Med (2007) 3.71
Disordered macrophage cytokine secretion underlies impaired acute inflammation and bacterial clearance in Crohn's disease. J Exp Med (2009) 3.58
Antipsychotic drugs and hyperglycemia in older patients with diabetes. Arch Intern Med (2009) 3.43
Neurobiological mechanisms of the placebo effect. J Neurosci (2005) 3.41
A multicenter pilot study of subcallosal cingulate area deep brain stimulation for treatment-resistant depression. J Neurosurg (2011) 3.30
Effect of rivastigmine on delay to diagnosis of Alzheimer's disease from mild cognitive impairment: the InDDEx study. Lancet Neurol (2007) 3.22
Medical illness and the risk of suicide in the elderly. Arch Intern Med (2004) 3.09
Subcallosal cingulate gyrus deep brain stimulation for treatment-resistant depression. Biol Psychiatry (2008) 3.00
In search of the emotional self: an fMRI study using positive and negative emotional words. Am J Psychiatry (2003) 2.78
Posttraumatic stress disorder: a state-of-the-science review. J Psychiatr Res (2005) 2.61
Deep brain stimulation for treatment-resistant depression: follow-up after 3 to 6 years. Am J Psychiatry (2011) 2.46
Harnessing neuroplasticity for clinical applications. Brain (2011) 2.45
Disease state prediction from resting state functional connectivity. Magn Reson Med (2009) 2.37
Misuse of the FDA's humanitarian device exemption in deep brain stimulation for obsessive-compulsive disorder. Health Aff (Millwood) (2011) 2.34
Zinc in depression: a meta-analysis. Biol Psychiatry (2013) 2.26
VNS therapy in treatment-resistant depression: clinical evidence and putative neurobiological mechanisms. Neuropsychopharmacology (2006) 2.24
An fMRI study of the Trail Making Test. Neuropsychologia (2005) 2.24
Unmasking disease-specific cerebral blood flow abnormalities: mood challenge in patients with remitted unipolar depression. Am J Psychiatry (2002) 2.23
Efficacy and safety of cholinesterase inhibitors in Alzheimer's disease: a meta-analysis. CMAJ (2003) 2.18
Differences in brain glucose metabolism between responders to CBT and venlafaxine in a 16-week randomized controlled trial. Am J Psychiatry (2007) 2.15
A meta-analysis of cytokines in Alzheimer's disease. Biol Psychiatry (2010) 2.06
Contribution of informant and patient ratings to the accuracy of the mini-mental state examination in predicting probable Alzheimer's disease. J Am Geriatr Soc (2003) 1.93
A tractography analysis of two deep brain stimulation white matter targets for depression. Biol Psychiatry (2008) 1.90
Atypical antipsychotic drugs and risk of ischaemic stroke: population based retrospective cohort study. BMJ (2005) 1.84
Risk and resilience markers in bipolar disorder: brain responses to emotional challenge in bipolar patients and their healthy siblings. Am J Psychiatry (2006) 1.84
Subcallosal cingulate deep brain stimulation for treatment-resistant unipolar and bipolar depression. Arch Gen Psychiatry (2012) 1.83
Benzodiazepine use and driving: a meta-analysis. J Clin Psychiatry (2009) 1.81
Corticolimbic brain reactivity to social signals of threat before and after sertraline treatment in generalized social phobia. Biol Psychiatry (2012) 1.78
Safety and efficacy of methylphenidate for apathy in Alzheimer's disease: a randomized, placebo-controlled trial. J Clin Psychiatry (2013) 1.73
Efficacy and safety of antidepressants for treatment of depression in Alzheimer's disease: a metaanalysis. Can J Psychiatry (2007) 1.72
Stuck in a rut: rethinking depression and its treatment. Trends Neurosci (2010) 1.60
Distributed self in episodic memory: neural correlates of successful retrieval of self-encoded positive and negative personality traits. Neuroimage (2004) 1.53
Neuropsychiatric symptoms in Alzheimer's disease: past progress and anticipation of the future. Alzheimers Dement (2013) 1.51
Neural stimulation successfully treats depression in patients with prior ablative cingulotomy. Am J Psychiatry (2008) 1.49
Receptor architecture of human cingulate cortex: evaluation of the four-region neurobiological model. Hum Brain Mapp (2009) 1.48
Deep brain stimulation for psychiatric disorders. Annu Rev Neurosci (2011) 1.47
The functional neuroanatomy of episodic and semantic autobiographical remembering: a prospective functional MRI study. J Cogn Neurosci (2004) 1.45
Recommendations of the 4th Canadian Consensus Conference on the Diagnosis and Treatment of Dementia (CCCDTD4). Can Geriatr J (2012) 1.39
Cerebral metabolic correlates as potential predictors of response to anterior cingulotomy for treatment of major depression. J Neurosurg (2003) 1.39
Defining the neural circuitry of depression: toward a new nosology with therapeutic implications. Biol Psychiatry (2007) 1.39
Effect of regulatory warnings on antipsychotic prescription rates among elderly patients with dementia: a population-based time-series analysis. CMAJ (2008) 1.34
Scientific and ethical issues related to deep brain stimulation for disorders of mood, behavior, and thought. Arch Gen Psychiatry (2009) 1.33
A functional magnetic resonance imaging (FMRI) study of cue-induced smoking craving in virtual environments. Appl Psychophysiol Biofeedback (2005) 1.33
Old and homeless: a review and survey of older adults who use shelters in an urban setting. Can J Psychiatry (2003) 1.30
An fMRI study investigating cognitive modulation of brain regions associated with emotional processing of visual stimuli. Neuropsychologia (2003) 1.29
State and trait influences on mood regulation in bipolar disorder: blood flow differences with an acute mood challenge. Biol Psychiatry (2003) 1.28
A meta-analysis of structural and functional brain imaging in dementia of the Alzheimer's type: a neuroimaging profile. Neuropsychol Rev (2003) 1.27
Probing brain reward system function in major depressive disorder: altered response to dextroamphetamine. Arch Gen Psychiatry (2002) 1.26
IPA survey of brief cognitive screening instruments. Int Psychogeriatr (2006) 1.26
Optimizing preprocessing and analysis pipelines for single-subject fMRI. I. Standard temporal motion and physiological noise correction methods. Hum Brain Mapp (2011) 1.22
Task-relevant modulation of contralateral and ipsilateral primary somatosensory cortex and the role of a prefrontal-cortical sensory gating system. Neuroimage (2002) 1.20
Deep brain stimulation for Parkinson's disease dissociates mood and motor circuits: a functional MRI case study. Mov Disord (2003) 1.19
Antidepressants for agitation and psychosis in dementia. Cochrane Database Syst Rev (2011) 1.18
Exposure to general anesthesia and risk of Alzheimer's disease: a systematic review and meta-analysis. BMC Geriatr (2011) 1.16
Predictors of nonresponse to cognitive behavioural therapy or venlafaxine using glucose metabolism in major depressive disorder. J Psychiatry Neurosci (2009) 1.16
Clustered functional MRI of overt speech production. Neuroimage (2006) 1.15
Recollection- and familiarity-based memory in healthy aging and amnestic mild cognitive impairment. Neuropsychology (2008) 1.13
Treatment resistant depression as a failure of brain homeostatic mechanisms: implications for deep brain stimulation. Exp Neurol (2009) 1.12
Depression beliefs, treatment preference, and outcomes in a randomized trial for major depressive disorder. J Psychiatr Res (2011) 1.12
Sharing the responsibility for assessing the risk of the driver with dementia. CMAJ (2007) 1.12
Partial k-space reconstruction in single-shot diffusion-weighted echo-planar imaging. Magn Reson Med (2007) 1.11
Retrospective coregistration of functional magnetic resonance imaging data using external monitoring. Magn Reson Med (2005) 1.11
Decreased cortical representation of genital somatosensory field after childhood sexual abuse. Am J Psychiatry (2013) 1.10
Physiotherapy coupled with dextroamphetamine for rehabilitation after hemiparetic stroke: a randomized, double-blind, placebo-controlled trial. Stroke (2005) 1.08
Antidepressants, warfarin, and the risk of hemorrhage. J Clin Psychopharmacol (2005) 1.07
Predictors of remission in depression to individual and combined treatments (PReDICT): study protocol for a randomized controlled trial. Trials (2012) 1.06
Antipsychotic use in the elderly: shifting trends and increasing costs. Int J Geriatr Psychiatry (2005) 1.06
Mild cognitive impairment: an operational definition and its conversion rate to Alzheimer's disease. Dement Geriatr Cogn Disord (2005) 1.06
Initiation of benzodiazepines in the elderly after hospitalization. J Gen Intern Med (2007) 1.05
In vivo characterization of traumatic brain injury neuropathology with structural and functional neuroimaging. J Neurotrauma (2006) 1.05
Brain activity during driving with distraction: an immersive fMRI study. Front Hum Neurosci (2013) 1.02
Methylphenidate for the treatment of apathy in Alzheimer disease: prediction of response using dextroamphetamine challenge. J Clin Psychopharmacol (2008) 1.02
Somatosensory gating and recovery from stroke involving the thalamus. Stroke (2002) 1.02
A new tablet for writing and drawing during functional MRI. Hum Brain Mapp (2011) 1.01
Pharmacological treatments for neuropsychiatric symptoms of dementia in long-term care: a systematic review. Int Psychogeriatr (2012) 1.01
The role of dopamine in symptoms and treatment of apathy in Alzheimer's disease. CNS Neurosci Ther (2010) 1.00
Effects of ω-3 fatty acids on cognitive performance: a meta-analysis. Neurobiol Aging (2012) 1.00
Investigation of fMRI neurofeedback of differential primary motor cortex activity using kinesthetic motor imagery. Neuroimage (2012) 1.00
Mental health-related drug utilization among older adults: prevalence, trends, and costs. Am J Geriatr Psychiatry (2005) 0.99
Functional MRI of working memory and selective attention in vibrotactile frequency discrimination. BMC Neurosci (2007) 0.99
How much are atypical antipsychotic agents being used, and do they reach the populations who need them? A Canadian experience. Clin Ther (2002) 0.99
Optimizing the experimental design for ankle dorsiflexion fMRI. Neuroimage (2004) 0.99
Tractography-activation models applied to subcallosal cingulate deep brain stimulation. Brain Stimul (2013) 0.99
Optimizing preprocessing and analysis pipelines for single-subject fMRI: 2. Interactions with ICA, PCA, task contrast and inter-subject heterogeneity. PLoS One (2012) 0.98
Persistence and adherence with dementia pharmacotherapy: relevance of patient, provider, and system factors. Can J Psychiatry (2014) 0.98
Spin-history artifact during functional MRI: potential for adaptive correction. Med Phys (2011) 0.98
The effects of lithium on renal function in older adults--a systematic review. J Geriatr Psychiatry Neurol (2012) 0.98